An observational study in Ischemia, sponsored by Spectros Corporation. Status unknown at 1 site in United States. Per ClinicalTrials.gov, last updated 2011-02-01.
Sponsored by Spectros Corporation · Observational
The purpose of the study is to understand the relevance of tissue oximetry measures of tissue flaps during surgery and during recovery, and to determine if T-Stat is a reliable and early method of detecting compromised flaps.
The tissue saturation of free flaps will be measured before, during, and after surgery and during recovery.
2,062 studies on the registry are indexed under Ischemia; 345 are open to participants now.
This study's planned enrollment of 50 is below the median of 184 across 618 observational studies indexed under Ischemia.
Browse Ischemia studies →Spectros Corporation is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients undergoing surgical breast reconstruction.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Flap Failure and Compromise by Tissue Saturation Values (Efficacy)
Time frame: 72 hours
Oximetric Diagnosis compared to Clinical Diagnosis, Doppler
Time frame: 72 hours
Device Safety Measures (safety)
Time frame: 72 hours
This study is status unknown, as verified in Jan 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Spectros Corporation